NWBO

NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics, Inc. (NWBO)

About NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.48
52 Week Low
$0.17
Market cap
371.3M
Dividend yield
0.00%
Volume
--
Avg. volume
3.4M
P/E ratio
-3.66

NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.48
52 Week Low
$0.17
Market cap
371.3M
Dividend yield
0.00%
Volume
--
Avg. volume
3.4M
P/E ratio
-3.66